Progress and Prospects: Advancements in Retroviral Vector Design, Generation, and Application
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Progress and Prospects: Advancements in Retroviral Vector Design, Generation, and Application
Authors
Keywords
-
Journal
HUMAN GENE THERAPY
Volume 22, Issue 10, Pages 1171-1174
Publisher
Mary Ann Liebert Inc
Online
2011-11-02
DOI
10.1089/hum.2011.2523
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Lentivectors are efficient tools to manipulate the dendritic cell cytoskeleton
- (2011) Joao Metelo et al. Cytoskeleton
- Lentivirus-Mediated RNA Interference Targeting Bax Inhibitor-1 Suppresses Ex Vivo Cell Proliferation and In Vivo Tumor Growth of Nasopharyngeal Carcinoma
- (2011) Xiang-yong Li et al. HUMAN GENE THERAPY
- Polyswitch Lentivectors: “All-in-One” Lentiviral Vectors for Drug-Inducible Gene Expression, Live Selection, and Recombination Cloning
- (2011) Marc Giry-Laterrière et al. HUMAN GENE THERAPY
- A Foamy Virus Vector System for Stable and Efficient RNAi Expression in Mammalian Cells
- (2011) Magdalini Papadaki et al. HUMAN GENE THERAPY
- Lentiviral Vectors Targeted to MHC II Are Effective in Immunization
- (2011) Alexander Ageichik et al. HUMAN GENE THERAPY
- Pseudotyping Lentiviral Vectors with Aura Virus Envelope Glycoproteins for DC-SIGN–Mediated Transduction of Dendritic Cells
- (2011) Steven Froelich et al. HUMAN GENE THERAPY
- Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
- (2011) David L. Porter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Large-Scale Manufacture and Characterization of a Lentiviral Vector Produced for Clinical Ex Vivo Gene Therapy Application
- (2010) Otto-Wilhelm Merten et al. HUMAN GENE THERAPY
- Lentiviral vectors for immune cells targeting
- (2010) Steven Froelich et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- Redirecting Lentiviral Vectors Pseudotyped with Sindbis Virus-Derived Envelope Proteins to DC-SIGN by Modification of N-Linked Glycans of Envelope Proteins
- (2010) K. Morizono et al. JOURNAL OF VIROLOGY
- Recent Advances in Lentiviral Vector Development and Applications
- (2010) Janka Mátrai et al. MOLECULAR THERAPY
- Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia
- (2010) Marina Cavazzana-Calvo et al. NATURE
- Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease
- (2010) Stefan Stein et al. NATURE MEDICINE
- Efficient construction of producer cell lines for a SIN lentiviral vector for SCID-X1 gene therapy by concatemeric array transfection
- (2009) R. E. Throm et al. BLOOD
- Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors
- (2009) Robert H Kutner et al. Nature Protocols
- Clinical Application of Lentiviral Vectors – Concepts and Practice
- (2008) Axel Schambach et al. CURRENT GENE THERAPY
- Visualization of targeted transduction by engineered lentiviral vectors
- (2008) K-I Joo et al. GENE THERAPY
- Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients
- (2008) Steven J. Howe et al. JOURNAL OF CLINICAL INVESTIGATION
- Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
- (2008) Salima Hacein-Bey-Abina et al. JOURNAL OF CLINICAL INVESTIGATION
- Inducible Packaging Cells for Large-scale Production of Lentiviral Vectors in Serum-free Suspension Culture
- (2008) Sophie Broussau et al. MOLECULAR THERAPY
- Engineered lentivector targeting of dendritic cells for in vivo immunization
- (2008) Lili Yang et al. NATURE BIOTECHNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More